# Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes

> **NCT00645840** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT00645840
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645840, "Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00645840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*